MAP Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

MAP Pharmaceuticals ( MAPP) focuses on the development and commercialization of drugs in the field of neurology using its inhalation technologies. This stock is trading up 6.2% at $15.40 in recent trading.

Today's Volume: 505,000

Average Volume: 192,397

Volume % Change: 409%

From a technical perspective, MAPP is rebounding sharply higher today following the stock's recent selloff from $17.50 to a low of around $14.50. Shares of MAPP are just starting to move back above its 50-day moving average today of $15.35 with monster volume.

Traders should continue to look for long biased trades as long as MAPP is trending above its 50-day with strong upside volume flows.

If you liked this article you might like

4 Stocks Under $10 Making Big Moves

5 Stocks Under $10 Set to Soar

4 Biotech Stocks Under $10 to Trade for Breakouts

4 Stocks Under $10 Making Big Moves

Transcept Pharmaceuticals Management Discusses Q2 2012 Results - Earnings Call Transcript